DE:PHE Stock Latest News
Company AnnouncementsCipher Pharmaceuticals Strengthens Board with Appointment of Industry Veteran Rajiv De Silva1M ago
Company AnnouncementsCipher Wins U.S. Court Ruling Upholding Absorica LD Arbitration Award Against Sun Pharma2M ago
Company AnnouncementsCipher Pharmaceuticals Balances U.S. Strain With Epuris Strength2M ago
Company AnnouncementsCipher Pharmaceuticals Balances Q2 Earnings Dip With Epuris Growth and Strong Balance Sheet2M ago
Pre-EarningsIs CPHRF a Buy, Before Earnings?2M ago
Company AnnouncementsCipher Pharmaceuticals Delivers Record 2025 Results and Primes for Next Acquisition Phase7M ago
Pre-EarningsIs CPHRF a Buy, Before Earnings?7M ago
Company AnnouncementsCipher Pharmaceuticals Sets March Date for Q4 and Fiscal 2025 Results8M ago
Company AnnouncementsCipher Wins Health Canada Review for Natroba Head Lice and Scabies Treatment9M ago
Company AnnouncementsCipher Pharmaceuticals Reports Strong Q3 2025 Financial Results11M ago
Company AnnouncementsCipher Pharmaceuticals Achieves Strong Q3 2025 Financial Performance11M ago
Pre-EarningsCipher Pharmaceuticals Inc (CPHRF) Q3 Earnings Cheat Sheet12M ago
Company AnnouncementsCipher Pharmaceuticals to Announce Q3 2025 Financial Results1y ago
Company AnnouncementsCipher Pharmaceuticals Wins Arbitration Against Sun Pharmaceuticals1y agoCompany AnnouncementsCipher Pharmaceuticals Mourns the Loss of Esteemed Board Member Harold Wolkin1y ago


